Drug giants threaten NHS with legal action over cheaper drug that could save 84 million pounds a year

The Guardian

1 November 2017 - Using cheaper version of drug effective against blindness is preferable to cost-cutting measures such as rationing, say NHS commissioners.

Two multinational drug companies are threatening legal action to prevent patients being offered a cheap version of an effective drug against blindness which could save the NHS millions of pounds.

Twelve NHS clinical commissioning groups in the north-east of England say that saving money by buying a safe and effective – but 10 times cheaper – version of the licensed drug for wet macular degeneration is far preferable to cutting costs in other ways, for instance by rationing fertility treatment or cataract operations.

Read The Guardian article

Michael Wonder

Posted by:

Michael Wonder